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Abstract
Introduction Objective cutaneous metastasis from carci-
noma of the uterine cervix is an uncommon occurrence. The
outcome of patients with skin metastasis is usually poor as
they are often associated with locoregional recurrence. This
metastasis impairs the quality of life and shortens survival.
Consequently, physicians should be aware of the possible
existence of skin metastasis in cervical cancer. Clinical suspi-
cion should lead to a careful additional evaluation whenever
a cutaneous nodule presents in the course of the disease.
Case report We report a rare case of metastasis from
squamous cell carcinoma of cervix to the umbilicus. The
patient was diagnosed with stage IIB FIGO. Four months
after chemoradiation patient presented with a nodule in the
umbilical region. Biopsy performed and metastatic squa-
mous cell carcinoma was diagnosed. Patient underwent
salvage therapy with paclitaxel and carboplatin.
Conclusion To the best of our knowledge, this is a rare
reported occurrence of umbilical metastasis in cervical can-
cer without prior laparotomy or laparoscopy. This meta-
static lesion has a grave prognosis and the mean survival is
about 3 months like our case.
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Introduction
Carcinoma of the cervix is the second most common neo-
plasm worldwide. Early detection and improved treatment
techniques have resulted in better control of cancer and
longer survival, however, invasive and metastatic disease
still occurs.
Carcinoma of the cervix recurs most commonly locore-
gionally after surgery and/or radiotherapy. Distant metas-
tases are rare and lungs, bone and liver are the main sites
[1, 2]. Metastasis to the skin occurs rarely, regardless of
the nature of the primary systemic neoplasm. Skin metas-
tasis originating from cervical cancer is particularly
unusual, even in the terminal stage of disease [3]. The
most common site of skin metastasis in carcinoma of cer-
vix is the anterior abdominal wall (especially at the drain
site), vulva, lower extremity and anterior chest wall [3–5].
We report a case of post-radiation carcinoma of cervix
stage IIB who had an umbilical metastasis which is a very
rare case of cutaneous metastasis, 4 months after comple-
tion of treatment.
Case report
A 53-year-old postmenopausal woman was referred on
July 2007 to the Gynecology Oncology Department, Vali-
e-Asr Hospital, Tehran Medical University, Iran, as a post-
radiation case of carcinoma cervix FIGO stage IIB. She
had earlier presented to the same department on December
2006 with complaint of vaginal bleeding lasted for
5 months. The pelvic examination revealed a 4-cm cervical
lesion extending to involve both parametrium. A cervical
biopsy conWrmed nonkeratinizing large cell squamous cell
carcinoma. On investigation, biochemistry proWles and
chest X-ray [postero-anterior (PA)] were within normal
limits. Computed tomographies of the abdomen and pelvis
were normal except parametrial involvement. No liver or
other distant metastasis was found. Intravenous pyelogra-
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490 Arch Gynecol Obstet (2008) 278:489–491phy, cystoscopy and proctoscopy were within normal lim-
its as well. She was thus staged as FIGO stage IIB. The
patient was treated by external beam radiotherapy (EBR)
with telecobalt equipment theratron 780. Whole pelvis
total dose was 54 Gy with four-Weld box technique
employed with anterior, posterior and two lateral Welds
with classic limits. EBR was given concomitant with inta-
venous weekly cisplatin 40 mg/m2. Totally the patient
received Wve platinum injections. Brachytherapy was per-
formed 2 weeks after EBR in two sessions 1 week apart.
The dose was prescribed at point A deWned by Manchester
system with tandem and two medium size colpostat with
low dose rate/medium dose rate selectron machine. We
used dose rate of 190 cGY/h and 12 Gy was given in each
session that made the total dose of brachytherapy to point
A 24 Gy with medium dose rate regimen. Radiotherapy
Wnished on February 2007. Four months after completion
of therapy, a soft tissue lesion in the region of the umbili-
cus developed. Local examination revealed an umbilical
lesion with watery discharge (Fig. 1).
Cervical biopsy showed persistent disease. MRI of the
abdomen and pelvis was performed and the only Wnding
was a mild increasing in the thickness of the posterior wall
of bladder. Abdomen computed tomography showed no
liver metastasis. Chest X-ray [postero-anterior (PA)] was in
normal limits. A skin biopsy performed for the patient and
metastatic squamous cell carcinoma was diagnosed
(Fig. 2). Salvage therapy initiated for the patient. Paclitaxel
at 160 mg/m2 was given, followed by intravenous infusion
of carboplatin dosed to an area under the curved of six
(maximum dose 600 mg) on day 1. She received six
courses with 3 weeks interval. Following two cycle of cis-
platin-based therapy, there was decrease in size of the
umbilical skin lesion. On the follow-up patient died after
3 months of receiving salvage therapy.
Discussion
The most common solid tumors metastasizing to the skin
are breast, gastrointestinal, and ovarian cancers [6]. Metas-
tasis to the skin occurs rarely in gynecologic cancer, espe-
cially in cervical carcinoma [3]. There has been no
diVerence in the incidence of skin metastasis among the
clinical stages [5]. The incidence of skin metastasis seemed
to be higher in patients with adenocarcinoma and undiVer-
entiated carcinoma than in patients with squamous cell car-
cinoma [7]. Our patient had stage IIB squamous cell
cervical carcinoma. In uterine cervical cancer, skin metas-
tasis has been reported in abdominal wall, vulva, anterior
chest wall and lower extremity [4, 5]. This is consistent
with other carcinomas in that the metastasis to the skin is
commonly located near the site of the primary tumor [8].
Skin metastases from cervical carcinoma occur predomi-
nantly in cases of tumor recurrences [3]. A review of litera-
ture shows that most of skin metastases occurred after an
interval less than 21 months except three cases reported by
Behtash et al. [3], Selo-Ojema et al. [9], Srivastava et al.
[10] although the second case was adenocarcinoma of the
cervix. In the present case, the patient developed umbilical
metastasis without prior laparascopy or laparotomy. Skin
involvement was observed directly, so that deduction con-
cerning its mechanism ought to be reliable and have appli-
cability to the general question of the mode of spread of
cervical cancer. The mechanism of involvement was
thought to be retrograde lymphatic spread from the corre-
sponding regional lymph nodes [10]. This Wnding seemed
important because it emphasized the predominant role of
lymphatics in the spread of cervical carcinoma.
The prognosis associated with cutaneous metastasis of
cervical carcinoma is poor. The mean reported survival of
these patients is 3 months [11]. These patients are notFig. 1 Umblical metastase
Fig. 2 Light microscopy123
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or metastatic disease. The intent of treatment remains palli-
ation either by radiation, chemotherapy, surgery alone or in
combinations [5]. Cis-platinum is the single most active
agent for controlling the symptoms [3], as we gave the
patient carboplatin in combination with paclitaxel.
The present case is unusual in that case metastasis
occurred to the normal skin (umbilical region) in squamous
cell carcinoma, stage IIB 4 months after completion of the
treatment and has a similar downhill course as reported in
the literature
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